Drug Profile
ONO 5129
Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Ono Pharmaceutical
- Class
- Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists; Peroxisome proliferator-activated receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 31 May 2006 Phase-II clinical trials in Type-2 diabetes mellitus in Japan (PO)
- 22 May 2006 This compound is still in active development
- 07 Jun 2005 Phase-II clinical trials in Diabetes mellitus in USA (PO)